Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer

被引:4
|
作者
Nakamura, Naoki [1 ]
Hojo, Hidehiro [1 ]
Inoue, Kazuya [2 ]
Hotta, Kenji [1 ]
Zenda, Sadamoto [1 ]
Baba, Hiromi [1 ]
Onozawa, Masakatsu [1 ]
Motegi, Atsushi [1 ]
Nakamura, Masaki [1 ]
Kibe, Yuichi [1 ]
Akimoto, Tetsuo [1 ]
机构
[1] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Takai Hosp, Dept Radiol, 470-8 Kuranosho, Tenri, Nara 6320006, Japan
关键词
lung cancer; radiation therapy; proton beam therapy; radiological change; STEREOTACTIC ABLATIVE RADIOTHERAPY; BODY RADIATION-THERAPY; MASS-LIKE CONSOLIDATION; INJURY; RECURRENCE; SBRT;
D O I
10.1093/jrr/rry028
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study aimed to examine late radiological changes after proton beam therapy (PBT) for early-stage non-small cell lung cancer (NSCLC) and to clarify correlations between mass-like radiological changes and patient characteristics. CT scans of patients who underwent passive scattering PBT for T1-2N0M0 NSCLC were analyzed retrospectively. Patients were considered eligible if follow-up CT was performed for at least 2 years, with no definite evidence of local recurrence. The following five periods were defined: (i) 6-12 months, (ii) 12-24 months, (iii) 24-36 months, (iv) 36-48 months and (v) 48-60 months after PBT. Late (>= 6 months) radiological changes were scored by consensus of three radiation oncologists according to classifications set forth by Koenig (Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 2002; 178: 1383-8.). CT scans of 113 patients (median follow-up, 36 months; range, 24-137 months) were evaluated. Late radiological changes during Periods (i), (ii), (iii), (iv) and (v) included modified conventional pattern (80%, 79%, 72%, 58% and 56%, respectively), mass-like changes (8%, 9%, 14%, 22% and 18%, respectively), scar-like changes (4%, 9%, 11%, 17% and 24%, respectively) and no increased density (8%, 3%, 3%, 2% and 2%, respectively). Mass-like changes were observed in 23 patients (20%). Among patients who developed mass-like changes, the median interval between the initiation of PBT and the onset of mass-like changes was 19 months (range, 6-62 months). In multivariate analysis, a peripheral location was found to be a significant factor (P = 0.035; odds ratio: 4.44; 95% confidence interval: 1.12-21.28). In conclusion, mass-like changes were observed in 20% of patients who underwent PBT. Patients with peripheral tumors showed a higher incidence of mass-like changes.
引用
收藏
页码:456 / 461
页数:6
相关论文
共 50 条
  • [31] Lobectomy versus proton therapy for stage I non-small cell lung cancer
    Sakane, Tadashi
    Nakajima, Koichiro
    Iwata, Hiromitsu
    Nakano, Tomoharu
    Hagui, Emi
    Oguri, Masanosuke
    Nomura, Kento
    Hattori, Yukiko
    Ogino, Hiroyuki
    Haneda, Hiroshi
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 166 (06): : 1490 - +
  • [32] Comparison between proton and photon beam therapy for limited-stage small cell lung cancer
    Seo, S. H.
    Pyo, H.
    Ahn, Y. C.
    Oh, D.
    Yang, K.
    Kim, N.
    Noh, J. M.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1064 - S1065
  • [33] Proton Beam Therapy for Early Stage Lung Cancer: A Multi-Institutional Retrospective Study in Japan
    Ohnishi, K.
    Harada, H.
    Nakamura, N.
    Tokumaru, S.
    Wada, H.
    Arimura, T.
    Iwata, H.
    Sato, Y.
    Sekino, Y.
    Tamamura, H.
    Mizoe, J.
    Ogino, T.
    Ishikawa, H.
    Kikuchi, Y.
    Okimoto, T.
    Murayama, S.
    Akimoto, T.
    Sakurai, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2405 - S2405
  • [34] Hypofractionated Proton Beam Therapy for Centrally Located Lung Cancer
    Nakamura, N.
    Hotta, K.
    Zenda, S.
    Baba, H.
    Fukuhara, S. K.
    Akita, T.
    Motegi, A.
    Hojo, H.
    Nakamura, M.
    Kibe, Y.
    Akimoto, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E698 - E698
  • [35] Proton beam therapy for locally advanced lung cancer: A review
    Schild, Steven E.
    Rule, William G.
    Ashman, Jonathan B.
    Vora, Sujay A.
    Keole, Sameer
    Anand, Aman
    Liu, Wei
    Bues, Martin
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 568 - 575
  • [36] Hypofractionated proton beam therapy for centrally located lung cancer
    Nakamura, Naoki
    Hotta, Kenji
    Zenda, Sadamoto
    Baba, Hiromi
    Kito, Satoe
    Akita, Tsunemichi
    Motegi, Atsushi
    Hojo, Hidehiro
    Nakamura, Masaki
    Parshuram, Raturi Vijay
    Okumura, Masayuki
    Akimoto, Tetsuo
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2019, 63 (04) : 552 - 556
  • [37] Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas
    Lee, Sung Uk
    Moon, Sung Ho
    Cho, Kwan Ho
    Pyo, Hong Ryull
    Kim, Joo Young
    Kim, Dae Yong
    Kim, Tae Hyun
    Suh, Yang-Gun
    Kim, Yeon-Joo
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (09) : 649 - 657
  • [38] Proton-beam radiotherapy for early-stage lung cancer
    Bush, DA
    Slater, JD
    Bonnet, R
    Cheek, GA
    Dunbar, RD
    Moyers, M
    Slater, JM
    CHEST, 1999, 116 (05) : 1313 - 1319
  • [39] Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC
    Gjyshi, Olsi
    Xu, Ting
    Elhammali, Adnan
    Boyce-Fappiano, David
    Chun, Stephen G.
    Gandhi, Saumil
    Lee, Percy
    Chen, Aileen B.
    Lin, Steven H.
    Chang, Joe Y.
    Tsao, Anne
    Gay, Carl M.
    Zhu, X. Ronald
    Zhang, Xiaodong
    Heymach, John V.
    Fossella, Frank V.
    Lu, Charles
    Nguyen, Quynh-Nhu
    Liao, Zhongxing
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) : 269 - 277
  • [40] Proton beam therapy is a safe and feasible treatment for patients with second primary lung cancer after lung resection
    Ono, Takashi
    Nakamura, Tatsuya
    Azami, Yusuke
    Suzuki, Motohisa
    Wada, Hitoshi
    Kikuchi, Yasuhiro
    Murakami, Masao
    Nemoto, Kenji
    THORACIC CANCER, 2019, 10 (02) : 289 - 295